The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 4, 2011, Pages 322-327

  Oh, Da Young ^a   Lagakos, William S ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

free fatty acid; G protein coupled receptor; glucose tolerance; inflammation; insulin resistance

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIINFLAMMATORY AGENT; BETA ARRESTIN 2; BINDING PROTEIN; FISH OIL; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; GAMMA INTERFERON; GLUCOSE; GPR119 PROTEIN; GPR41 PROTEIN; GPR43 PROTEIN; GPR84 PROTEIN; INSULIN; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; LONG CHAIN FATTY ACID; N OLEOYLETHANOLAMINE; POLYUNSATURATED FATTY ACID; PROTEIN P40; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BASAL METABOLIC RATE; BINDING AFFINITY; BODY TEMPERATURE; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DIETARY FIBER; DIETARY INTAKE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; ENZYME INHIBITION; FATTY LIVER; FOOD INTAKE; GENE LOSS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYDROPHOBICITY; HYPERGLYCEMIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE FLORA; INTESTINE TRANSIT TIME; LIGAND BINDING; MACROPHAGE; METABOLIC DISORDER; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STOMACH MOTILITY; TH1 CELL; TIGHT JUNCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, OMEGA-3; GENE DELETION; GLUCOSE INTOLERANCE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTESTINAL ABSORPTION; MACROPHAGES; MICE; OBESITY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79959263075     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283479230     Document Type: Review

References (39)

1. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004; 89:463-478. (Pubitemid 38269844)
2. Kraegen EW, Cooney GJ, Ye JM, et al. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2):S189-S201. (Pubitemid 32577582)
3. Riccardi G. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes. Nutr Metab Cardiovasc Dis 2000; 10:104-107.
4. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277:50230-50236. (Pubitemid 36042170)
5. Chavez JA, Knotts TA, Wang LP, et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278:10297-10303. (Pubitemid 36800291)
6. Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350:664-671. (Pubitemid 38364625)
7. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420:333-336. (Pubitemid 35398190)
8. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293:1673-1677. (Pubitemid 32807849)
9. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 2003; .27. (Suppl 3):S6-S11. (Pubitemid 38019180)
10. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 2000; 21:90-113. (Pubitemid 32260396)
11. Schulte G, Fredholm BB. Signalling from adenosine receptors to mitogenactivated protein kinases. Cell Signal 2003; 15:813-827. (Pubitemid 36776656)
12. Tazoe H, Otomo Y, Kaji I, et al. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 2008; 59 (Suppl 2):251-262.
13. Wang J, Wu X, Simonavicius N, et al. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem 2006; 281:34457-34464. (Pubitemid 46036653)
14. Itoh Y, Kawamata Y, Harada M, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003; 422:173-176. (Pubitemid 36362750)
15. Hirasawa A, Tsumaya K, Awaji T, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90-94. (Pubitemid 40215843)
16. Piomelli D. The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 2005; 6:672-679. (Pubitemid 40904037)
17. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004; 10:355-361. (Pubitemid 38508511)
18. Briscoe CP, Tadayyon M, Andrews JL, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 2003; 278:11303-11311. (Pubitemid 36792687)
19. Kotarsky K, Nilsson NE, Flodgren E, et al. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem Biophys Res Commun 2003; 301:406-410. (Pubitemid 36279253)
20. Steneberg P, Rubins N, Bartoov-Shifman R, et al. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 2005; 1:245-258. (Pubitemid 43960613)
21. Tan CP, Feng Y, Zhou YP, et al. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Diabetes 2008; 57:2211-2219.
22. Kebede M, Alquier T, Latour MG, et al. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding. Diabetes 2008; 57:2432-2437.
23. Brown AJ, Goldsworthy SM, Barnes AA, et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278: 11312-11319. (Pubitemid 36792688)
24. Le Poul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278:25481-25489. (Pubitemid 36835299)
25. Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G proteincoupled receptor, GPR41. Proc Natl Acad Sci USA 2008; 105:16767-16772.
26. Eastwood M, Kritchevsky D. Dietary fiber: how did we get where we are? Annu Rev Nutr 2005; 25:1-8. (Pubitemid 41208991)
27. Karaki S, Mitsui R, Hayashi H, et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 2006; 324:353-360. (Pubitemid 43673476)
28. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461:1282-1286.
29. Bjursell M, Admyre T, Goransson M, et al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a highfat diet. Am J Physiol Endocrinol Metab 2011; 300:E211-E220.
30. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-551. (Pubitemid 40585355)
31. Larsen CN, Nielsen S, Kaestel P, et al. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus paracasei subsp. paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 2006; 60:1284-1293. (Pubitemid 44669696)
32. Lee T, Schwandner R, Swaminath G, et al. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol 2008; 74:1599-1609.
33. Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G proteincoupled receptor for oleoylethanolamide and its use in the discovery of smallmolecule hypophagic agents. Cell Metab 2006; 3:167-175.
34. Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 2009; 58:1058-1066.
35. Chu ZL, Jones RM, He H, et al. A role for beta-cell-expressed G proteincoupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 2007; 148:2601-2609. (Pubitemid 46984798)
36. Chu ZL, Carroll C, Alfonso J, et al. A role for intestinal endocrine cellexpressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 2008; 149:2038-2047. (Pubitemid 351574507)
37. Madiraju SR, Poitout V. G protein-coupled receptors and insulin secretion: 119 and counting. Endocrinology 2007; 148:2598-2600. (Pubitemid 46984778)
38. Flock G, Holland D, Seino Y, Drucker DJ. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Endocrinology 2011; 152:374-383.
39. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142:687-698.